Sign in

Ghazaleh Tabatabai

@ghtabatabai.bsky.social
156 followers 103 following 16 posts

Neurologist.Physician Scientist. Neurooncologist. Molecular Biology. Early PhaseClinical Trials. Full Professor&Managing Director. Passionate about Music&Literature. @unituebingen.bsky.social @neurooncotue.bsky.social

PostsRepliesMedia
Reposted by Ghazaleh Tabatabai
Neurooncology Tuebingen @neurooncotue.bsky.social · 22/05/2026
We are very happy to present you our work, recently accepted in Neurooncology! @ghtabatabai.bsky.social @hih-tuebingen.bsky.social academic.oup.com/neuro-oncolo...
academic.oup.com
Molecular modulators of CDK4/6 inhibitor response in experimental glioma identified through genome-wide CRISPR-Cas9 screening
AbstractBackground. Glioblastoma harbors frequent alterations in the retinoblastoma (RB1) pathway, providing a genetic rationale for therapeutic targeting
033
Reposted by Ghazaleh Tabatabai
Hannes Becker @hannes-becker1996.bsky.social · 14/11/2025
Very happy to had the opportunity to present our data at the DGN in Berlin. @ghtabatabai.bsky.social @hih-tuebingen.bsky.social @dgn-ev.bsky.social
022
Reposted by Ghazaleh Tabatabai
Neurooncology Tuebingen @neurooncotue.bsky.social · 14/11/2025
We are very happy to present our data at the DGN in Berlin! @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @dgn-ev.bsky.social
031
Reposted by Ghazaleh Tabatabai
Neurooncology Tuebingen @neurooncotue.bsky.social · 21/10/2025
We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions! Looking forward to Rome! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social
0105
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 19/10/2025
#EANO2025 in Prague has come to a close – what an inspiring meeting of science, learning, and collaboration! Thank you to all who contributed to this year’s success. Together we advance #NeuroOncology and improve care for people with brain tumours. #EANO #btsm
0144
Reposted by Ghazaleh Tabatabai
Neurooncology Tuebingen @neurooncotue.bsky.social · 18/10/2025
Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social
094
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 17/10/2025
And now it‘s Hannes Becker on stage, presenting our data at EANO2025 👍🏼🙌 @neurooncotue.bsky.social
061
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 17/10/2025
Just happening. Max Niyazi on stage at EANO 2025 👍🏼💡
172
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 17/09/2025
Happening now 🙌😀 iFIT Lunch & Learn with Lisa Sevenich! @hih-tuebingen.bsky.social @unituebingen.bsky.social @lisasevenich.bsky.social
020
Reposted by Ghazaleh Tabatabai
Deutsche Forschungsgemeinschaft @dfg.de · 04/06/2025
Erfolge in der Wissenschaft müssen auch gefeiert werden – und das haben wir bei der Verleihung der Heinz Maier-Leibnitz-Preise 2025 getan. 10 DFG-geförderte Forscher*innen haben sich in ihrem jeweiligen Fach verdient gemacht und wurden nun von DFG-Generalsekretärin Heide Ahrens in Berlin gewürdigt.
“Anerkennung als Ansporn”
Verleihung der Heinz Maier-Leibnitz-Preise
»Aufmerksamkeit für herausragende Forschungsleistungen in frühen Karrierephasen ist das Hauptmotiv dieses Preises, der außergewöhnliche Güte und Originalität auszeichnet und ermutigen soll, den eingeschlagenen wissenschaftlichen Weg selbstbewusst weiterzuverfolgen.« 
Zitat DFG-Generalsekretärin Dr. Heide Ahrens
0164
Reposted by Ghazaleh Tabatabai
Wissenschaftsrat @wissenschaftsrat.de · 04/06/2025
Wissenschaft braucht verlässliche Infrastrukturen - viele davon liegen noch in den USA. Der WR-Vorsitzende @wickwolfgang.bsky.social fordert in der @faznet.bsky.social eine europäische Strategie für mehr Unabhängigkeit👉 www.faz.net/aktuell/wiss... #DigitaleSouveränität #Forschung #Infrastruktur
Der Wissenschaftsrats-Vorsitzende Wolfgang Wick mit dem nebenstehenden Zitat "Wir brauchen eigenständige Wissenschaftsinfrastrukturen in Europa", das aus einem FAZ-Gastbeitrag vom 4.6.25 stammt.
064
Reposted by Ghazaleh Tabatabai
Martin Jungkunz @martin-jk.bsky.social · 30/05/2025
(6/6) Wir freuen uns auf Eure Ideen, Energie und Unterstützung – live in Heidelberg oder digital! Euer Team von Wissenschaft für Demokratie – Wir für Dich e.V. #Demokratie #Wissenschaft #Zivilgesellschaft #PolitischeBildung #Wisskomm #FaktenStattFake #Heidelberg #HybridEvent #Mitmachen
023
Reposted by Ghazaleh Tabatabai
Martin Jungkunz @martin-jk.bsky.social · 30/05/2025
(5) 👉 Den Mitgliedsantrag findet Ihr hier: lnkd.in/d8DbYXwx 📃 Satzung & Gebührenordnung: lnkd.in/dRkerMCd 📩 Anmeldung bitte per E-Mail an: info@wissenschaftfuerdemokratie.de (Zugangsdaten für Zoom und Teilnahmevoraussetzungen folgen nach Anmeldung.)
123
Reposted by Ghazaleh Tabatabai
Martin Jungkunz @martin-jk.bsky.social · 30/05/2025
(1) 🎉 Einladung: Der Verein „Wissenschaft für Demokratie – Wir für Dich“ stellt sich vor! 🎉 Aus der zivilgesellschaftlichen Initiative „Aufstehen für Demokratie“ wurde mit der Gründung am 23.5.2025 ein gemeinnütziger Verein – nun laden wir Euch herzlich zur Auftaktveranstaltung ein.
133
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 30/05/2025
⏱️Clock is ticking! The European Association of Neuro-Oncology (#EANO) and @neuroonc.bsky.social are accepting applications for the Editor-in-Chief of Neuro-Oncology Advances (NOA). Learn more: bit.ly/4j9AqV7 👉Application deadline: May 31, 2025
011
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 30/05/2025
🧠 Recently published in Neuro-Oncology: Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes 🔗 doi.org/10.1093/neuo... #EANOessentials #NeuroOncology #Meningioma #CNS
doi.org
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes
AbstractBackground. Meningiomas are the most common primary intracranial neoplasms, with highly variable patient outcomes. While most meningiomas are benig
042
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 30/05/2025
Live from #ASCO25 in Chicago: presentation of latest results on HER3-DXd efficacy and safety in patients with leptomeningeal metastatic disease of solid tumors - with simultaneous publication in Nature Medicine. Learn more: doi.org/10.1038/s415... #NeuroOncology
094
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 20/05/2025
Just happening 😀👌👏🫶 @hih-tuebingen.bsky.social @unituebingen.bsky.social @unistuttgart.bsky.social
151
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 20/04/2025
Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters
0113
Reposted by Ghazaleh Tabatabai
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 20/04/2025
This Easter, we extend our gratitude and admiration to our ICOM members and medical community for your relentless dedication to advancing medicine and transforming lives. We hope you’re able to take some time to spend with your loved ones and relax!
Happy Easter
021
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 18/04/2025
🧠 A new article on the characteristics, outcomes, and prognostic factors of young patients with WHO grade 3 oligodendrogliomas (IDH-mutant and 1p/19q codeleted) can be found in Cancer. Full article👉 acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #EANOessentials #NeuroOncology #Oligodendroglioma
acsjournals.onlinelibrary.wiley.com
Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH‐mutant and 1p/19q codeleted: A French POLA netwo...
Young patients under 40 years of age with grade 3 oligodendroglioma show distinct molecular profiles, including fewer CDKN2A deletions and specific chromosomal abnormalities, compared to those over 4....
063
Reposted by Ghazaleh Tabatabai
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 18/04/2025
This new report by several ICOM authors in JAMA Oncology highlights the importance of a role for #CytogeneticProfiling in the next iteration of #CNS WHO grading. Read the full report now: bit.ly/3EmWNb2 @gelarehzadeh.bsky.social @justinzwang.bsky.social
042
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 14/04/2025
🧬A recent study published in @jama.com explores the role of Chromosome 1p loss and 1q gain for improved grading of meningiomas.🔍 Learn more: jamanetwork.com/journals/jam... #EANOessentials #NeuroOncology #Meningioma #Neurosurgery
jamanetwork.com
Chromosome 1p Loss and 1q Gain for Grading of Meningioma
This cohort study examines chromosomal copy number alterations that could be used to improve the current World Health Organization grading of meningioma
086
Reposted by Ghazaleh Tabatabai
International Consortium on Meningiomas (ICOM) @icomeningioma.bsky.social · 11/04/2025
The upcoming #CNO meeting includes a session on #meningiomas from two of our wonderful #ICOM members @FarshadNassiri and Dr. Serge Makarenko. Read the full agenda here: bit.ly/4j3fDT6
CNO 2025 session 1: meningioma
032
Reposted by Ghazaleh Tabatabai
Hertie-Institut für klinische Hirnforschung (HIH) @hih-tuebingen.bsky.social · 09/04/2025
🙌 It's been a wonderful PhD Retreat at the HIH yesterday, with lots of time for exchange, poster sessions and the election of the new PhD representatives: Stefano Iavarone, Niloofar Mokhtari @estherkuehn.bsky.social & Surender Surender @ghtabatabai.bsky.social 🎉
094
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 09/04/2025
Freue mich wieder auf die neuen Erstsemester-Studierenden Humanmedizin, tolle Organisation von Fachschaft und Mentorenprogramm Medizin 😀😀🙌👏
060
Reposted by Ghazaleh Tabatabai
Nuclear Medicine and Neurooncology (NMN) @nmnsymposium.bsky.social · 04/04/2025
🤩 Attend the "Understanding theranostics" session at #NMN2025 and register here: www.nmn-society.org/registration/! #theranostics #btsm
032
Reposted by Ghazaleh Tabatabai
The New York Times @nytimes.com · 06/04/2025
People packed the streets across the U.S. on Saturday to protest against President Trump, his administration's cutbacks, financial turmoil and more. nyti.ms/43GRvS7
1572504492
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 08/03/2025
🙌 Celebrating Women in #NeuroOncology! On #InternationalWomensDay, we honor the contributions of researchers, clinicians, and healthcare professionals advancing the field. EANO is proud to support and empower women in science & medicine! 💜 #IWD2024 #WomenInScience #Neurosurgery #AHP #btsm
0112
Reposted by Ghazaleh Tabatabai
EANO @eanoassociation.bsky.social · 05/03/2025
🚀Abstract submission for #EANO2025 is open! Share your #NeuroOncology research at the 20th #EANO Meeting in Prague, Oct 16-19, 2025. We can't wait to see your contributions! 🗓️ Deadline: April 30, 2025, 23:59 CEST. 🔗 Details: www.eano.eu/eano2025/abs... #btsm #braintumor
0119
Reposted by Ghazaleh Tabatabai
Deutsche Gesellschaft für Neurologie (DGN) e.V. @dgn-ev.bsky.social · 06/03/2025
DGN-Kongress 2025: Jetzt mitgestalten und Vorschläge für das wissenschaftliche Programm und die interprofessionelle #Neurologie einreichen! 📅 Deadline: 31. März 2025. ➡️ dgn.org/dgn-kongress... #neuroscience #neuroskyence
031
Reposted by Ghazaleh Tabatabai
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 06/03/2025
For readers interested in cancer therapies, this Review in the March issue discusses therapeutic targeting of the metabolic dysfunction of CD8 T cells and natural killer cells in cancer www.nature.com/articles/s41... rdcu.be/ecsNM
Cancer metabolism
0115
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 20/02/2025
Tübingen 20 Feb 2025 #aufstehenfuerdemokratie
072
Reposted by Ghazaleh Tabatabai
Nuclear Medicine and Neurooncology (NMN) @nmnsymposium.bsky.social · 09/02/2025
📡 Listen to the @neuroonc.bsky.social podcast with @nathaliealbert.bsky.social on measurable disease with FET-PET vs. MRI in glioblastoma: soc-neuro-onc.libsyn.com/measurable-d...! @eanoassociation.bsky.social @eortc.bsky.social
053
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 12/02/2025
Tübingen 12 Feb 2025 Geschwister Scholl Platz Democracy needs facts Science needs Democracy. #aufstehenfuerdemokratie
0125
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 12/02/2025
Tübingen, 12 Feb 2025 Geschwister-Scholl-Platz „Democracy needs facts. Science and Innovation need Democracy“ #aufstehenfuerdemokratie
060
Reposted by Ghazaleh Tabatabai
Universität Tübingen @unituebingen.bsky.social · 13/01/2025
Science Podcast KEY TO MY RESEARCH: 🚀 Can we reprogram life? "The genome is like a code that controls life." — Prof. Dr. Hannes Link. In this Podcast episode: 🔹 Unlocking metabolism 🔹 Using CRISPR to rewrite DNA 🧬 🔹 Engineering bacteria to fix CO₂ 🌍 🎧 All episodes: uni-tuebingen.de/en/269679
041
Reposted by Ghazaleh Tabatabai
Universität Tübingen @unituebingen.bsky.social · 17/01/2025
"Do Objects Party Alone?" - Professor Dorothee Kimmich discusses the curious life of objects in #ModernLiterature. What if things around us could speak or live? Her #research rethinks the boundary between nature and culture, material and spirit. 👉 uni-tuebingen.de/en/269679 #Podcast #CulturalTheory
082
Reposted by Ghazaleh Tabatabai
Universität Tübingen @unituebingen.bsky.social · 24/01/2025
Did art save Homo Sapiens? Prof. Nicholas Conard shares how creativity gave us an edge in KEY TO MY RESEARCH. “Every group of human beings we know has art.” uni-tuebingen.de/exzellenzstr... #Podcast #Archaeology #HumanEvolution
062
Reposted by Ghazaleh Tabatabai
Universität Tübingen @unituebingen.bsky.social · 13/01/2025
👍 Herzlich Willkommen auf dem Bluesky-Account der #unituebingen. Wir posten ab sofort hier und auf unseren anderen Kanälen, z.B. Instagram, Facebook, LinkedIn, Mastodon. Unsere Aktivitäten auf X haben wir beendet.
88814
Reposted by Ghazaleh Tabatabai
Deutsche Gesellschaft für Neurologie (DGN) e.V. @dgn-ev.bsky.social · 08/01/2025
Wir begrüßen Prof. Dr. Daniela Berg, Direktorin der Klinik für Neurologie am UKSH, Campus Kiel, als neue Präsidentin der DGN! Welche Ziele sie sich gesetzt hat, erklärt sie hier: dgn.org/mediathek/vi... #neuroskyence #prävention #neurologie
0111
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 07/01/2025
NEW publication from our Lab 🥳💫🥳Genome-wide CRISPR-Cas9 screens identify identify BCL family members as modulators of response to regorafenib in experimental glioma. @neurooncotue.bsky.social pubmed.ncbi.nlm.nih.gov/39756423/
pubmed.ncbi.nlm.nih.gov
Genome-wide CRISPR-Cas 9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma - PubMed
This preclinical study uses a functional genomics-based target discovery approach with subsequent validations involving regorafenib. It serves as a biological rationale for clinical translation. Parti...
0123
Reposted by Ghazaleh Tabatabai
Ivy Brain Tumor Center @ivycenter.bsky.social · 23/12/2024
📢The Gliofocus Study is now open in the EU! Led by Dr. Mehdi Touat in Paris and Dr. Juan Manuel Sepulveda Sanchez in Madrid, this Phase 3 clinical trial compares niraparib to TMZ in nGBM. 68 EU medical centers are in the global Gliofocus Study network. 🔗Gliofocus.org
011
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 25/12/2024
Merry Christmas and very best wishes für 2025! @hih-tuebingen.bsky.social @unituebingen.bsky.social @neurooncotue.bsky.social
171
Reposted by Ghazaleh Tabatabai
Varun Venkataramani @venkataramanilab.bsky.social · 06/12/2024
🧵Just in time for : New research from the Venkataramani lab @CellCellPress maps how brain tumor cells create extensive neural networks in glioblastoma. Check out our paper here: authors.elsevier.com/sd/article/S... @ekinreyhan.bsky.social @svenjaktetzlaff.bsky.social 1/15
25116
Ghazaleh Tabatabai @ghtabatabai.bsky.social · 05/12/2024
Just happening in Tübingen: Great talk by Prof Ulrich Dirnagl on Research Integrity 🙌💡👍🏼 @hih-tuebingen.bsky.social
052
Reposted by Ghazaleh Tabatabai
Science News @scinews.bsky.social · 25/11/2024
In case some mentors may want to read this. #Nature #PhD #scisky #student #mentor Source: www.researchgate.net/publication/...
516061
Reposted by Ghazaleh Tabatabai
Science News @scinews.bsky.social · 05/12/2024
What is the best time of the month to treat breast cancer? #Nature "Breast Cancer: Menstrual cycle may affect chemotherapy sensitivity" Open Access www.nature.com/articles/s41...
1299
Reposted by Ghazaleh Tabatabai
Science News @scinews.bsky.social · 05/12/2024
🎯Tips For PhD students How to Write A Nature Abstract #MIT #Nature #PhD #Postdocs Read more mitcommlab.mit.edu/broad/commki...
05712
Reposted by Ghazaleh Tabatabai
Steven Corsello @corsello.bsky.social · 25/11/2024
Stanford Hematology has launched a physician scientist search! Research program can be lab-based and/or translational. facultypositions.stanford.edu/en-us/job/49...
facultypositions.stanford.edu
Stanford | Faculty Positions: Details - Hematology Physician Scientist
032